Fundz

Radius Promotes Jonathan Haseler to Divisional Chief Executive Officer for Fuel and EV

PRIVATEMay 02, 2026

Position

Chief Executive Officer

Company

Radius

Jonathan Haseler
BiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Description

Radius has promoted Jonathan Haseler to the position of Divisional Chief Executive Officer for Fuel and EV, enhancing its leadership in the transition from traditional fuel to electric vehicles. His new role will focus on leading Radius’ global strategy for Fuel and EV.

Quick answer

Radius Promotes Jonathan Haseler to Divisional Chief Executive Officer for Fuel and EV (May 2, 2026).

Who is the new Chief Executive Officer at Radius?
Radius named Jonathan Haseler Chief Executive Officer, announced May 2, 2026.
What did Radius announce on May 2, 2026?
Radius has promoted Jonathan Haseler to the position of Divisional Chief Executive Officer for Fuel and EV, enhancing its leadership in the transition from traditional fuel to electric vehicles. His new role will focus on leading Radius’ global strategy for Fuel and EV.
What does Radius do?
Radius is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, neuro- orphan diseases, and oncology.
Which similar companies made leadership changes around the same time?
Menarini Group (May 7, 2026), Juvisé Pharmaceuticals (April 16, 2026), NRx Pharmaceuticals (April 13, 2026) and Abivax (April 12, 2026) also announced leadership changes within 45 days of Radius.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Radius, and when

A new leader at Radius brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Radius raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Radius, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Radius. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Radius

Location

Peachtree Street Ne

About

Radius is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, neuro- orphan diseases, and oncology. Radius’ lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Radius clinical pipeline includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; the investigational drug, elacestrant (RAD1901), for potential use in the treatment of hormone-receptor positive breast cancer out-licensed to Menarini Group; and the investigational drug RAD011, a synthetic cannabidiol oral solution with potential utilization in multiple neuro-endocrine, neurodevelopmental, or neuropsychiatric disease areas, initially targeting Prader-Willi syndrome, Angelman syndrome, and infantile spasms.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Radius changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Radius's next move

Learn about Strategic plan

Radius changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.